[Brain tissue damage following the management of cardiazol-induced convulsions. Animal experimental contribution].
D000818:Animals; D001921:Brain / Q000503:physiopathology*; D009202:Cardiomyopathies / Q000209:etiology; D002415:Cats; D002531:Cerebellum / Q000503:physiopathology; D004565:Electroconvulsive Therapy; D004597:Electroshock; D005625:Frontal Lobe / Q000503:physiopathology; D006624:Hippocampus / Q000503:physiopathology; D007275:Injections, Intravenous; D008636:Mesencephalon / Q000503:physiopathology; D009778:Occipital Lobe / Q000503:physiopathology; D010296:Parietal Lobe / Q000503:physiopathology; D010433:Pentylenetetrazole; D011817:Rabbits; D012640:Seizures / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D013702:Temporal Lobe / Q000503:physiopathology
Zur Frage der Hirngewebsschädigungen nach Cardiazolkrampfbehandlung. Ein tierexperimenteller Beitrag.